OmniVis technology uses a revolutionary sensing technique to quantify and analyze biomolecular solutions directly at the source. Developed by co-founders Katherine Clayton, Tamara Kinzer-Ursem, Jacqueline Linnes, and Steve Wereley at Purdue University, their easy-to-use hardware device and consumable test kit attaches to a smartphone and reduces the detection process to 30 minutes, accurately and affordably.
Impact of I-Corps
The I-Corps program helped OmniVis define the ecosystem of their market segment, identify customer need, and focus on a first minimal viable product. Having gone through the program, Drs. Clayton and Kinzer-Ursem have honed their skills in identifying knowledge gaps and acquiring key insights through the Customer Discovery Process.
University Affiliation: Purdue University
From left to right: Dr. Katherine Clayton, PhD, Dr. Tamara Kinzer-Ursem, PhD, Dr. Steve Wereley, PhD, and Dr. Jackie Linnes, PhD
| Oct 2016 | Participated in Purdue I-Corps Site Biomedship Graduate Course |
| Feb 2017 | 2nd Place at Burton Morgan Business Plan Competition |
| Mar 2017 | Challenge Round at Rice Business Plan Competition |
| Jun 2017 | 1st place in Vodaphone Wireless Innovation Project |
| Oct 2017 | 2nd runner up in Cisco Innovation Challenge |
| Mar 2018 | NSF I-Corps Bay Area Cohort |
| Apr 2018 | Chosen as ‘Changing Idea Finalist’ in Fast Company |
| Apr 2018 | Finalist for the Project Entrepreneur Competition aimed at women founders through Rent the Runway and UBS |
| Jun 2018 | Awarded NSF SBIR Phase I ($225,000) |
| Jun 2018 | Accepted into NYC Project Entrepreneur Accelerator Program while incubating at Samsung NEXT NY |
| Sept 2018 | Recipient of Humanitarian Grand Challenge awarded by Grand Challenges Canada, UK DFID, and USAID |
